ElsaLys Biotech Overview
- Year Founded
-
2013
- Status
-
Acquired/Merged
- Employees
-
14
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
6
ElsaLys Biotech General Information
Description
Operator of a clinical-stage immuno-oncology company based in Lyon, France. The company designs and develops a new generation of therapeutic antibodies that target tumors and their immune and/or vascular microenvironment.
Contact Information
Website
www.elsalysbiotech.comCorporate Office
- 317 Avenue Jean Jaurès
- 69007 Lyon
- France
Corporate Office
- 317 Avenue Jean Jaurès
- 69007 Lyon
- France
ElsaLys Biotech Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
ElsaLys Biotech Patents
ElsaLys Biotech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3048799-A1 | Compounds binding human cd160 and uses thereof | Pending | 06-Jan-2017 | ||
| EP-3565593-A1 | Compounds binding human cd160 and uses thereof | Inactive | 06-Jan-2017 | ||
| US-10975159-B2 | Compounds binding human cd160 and uses thereof | Inactive | 06-Jan-2017 | ||
| US-20200109211-A1 | Compounds binding human cd160 and uses thereof | Active | 06-Jan-2017 | ||
| WO-2018127586-A1 | Compounds binding human cd160 and uses thereof | Inactive | 06-Jan-2017 | C07K16/2896 |
ElsaLys Biotech Signals
ElsaLys Biotech Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
ElsaLys Biotech FAQs
-
When was ElsaLys Biotech founded?
ElsaLys Biotech was founded in 2013.
-
Where is ElsaLys Biotech headquartered?
ElsaLys Biotech is headquartered in Lyon, France.
-
What is the size of ElsaLys Biotech?
ElsaLys Biotech has 14 total employees.
-
What industry is ElsaLys Biotech in?
ElsaLys Biotech’s primary industry is Drug Discovery.
-
Is ElsaLys Biotech a private or public company?
ElsaLys Biotech is a Private company.
-
What is ElsaLys Biotech’s current revenue?
The current revenue for ElsaLys Biotech is .
-
How much funding has ElsaLys Biotech raised over time?
ElsaLys Biotech has raised $5.76M.
-
Who are ElsaLys Biotech’s investors?
Alsace BioValley, Bpifrance, Credit Agricole, Institut Mérieux, and SEMIA Incubateur d' Alsace are 5 of 7 investors who have invested in ElsaLys Biotech.
-
When was ElsaLys Biotech acquired?
ElsaLys Biotech was acquired on 07-May-2020.
-
Who acquired ElsaLys Biotech?
ElsaLys Biotech was acquired by Mediolanum Farmaceutici.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process